LSE:GSKPharmaceuticals
GSK (LSE:GSK): Evaluating Valuation After a Strong Share Price Rally
GSK (LSE:GSK) has quietly kept climbing this year, and with the shares up around 43% over the past year and nearly 25% in the past 3 months, investors are taking notice.
See our latest analysis for GSK.
That momentum has not come out of nowhere, with a solid run of clinical updates, resilient demand for its vaccines and specialty medicines, and a rising dividend combining to push GSK’s share price steadily higher and deliver strong multi year total shareholder returns.
If GSK’s recent climb...